Trial intelligence / Profile preview

ASC-Enriched Lipofilling for Breast Augmentation and Facial Filling

NCT03258164Phase 3Completed

Sponsor
Stemform
Start
Mar 2017
Primary completion
Oct 2022
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of adipose derived mesenchymal stromal cells in breast hypoplasia, sponsored by Stemform. Started Mar 2017; status: completed.

02

Drugs

adipose derived mesenchymal stromal cells
03

Conditions

breast hypoplasia

Beyond the preview

Go deeper on NCT03258164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03258164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call